Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • FERRER, I; ROIG, C; ESPINO, A; PEIRO, G; Guiu, XM

    DEMENTIa OF FRONTaL-LOBE TYPE aND MOTOR-NEURON DISEaSE - a GOLGI-STUDY OF THE FRONTaL-CORTEX

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 54 932-934. .

    [doi:10.1136/jnnp.54.10.932]

  • ESQUIUS, J; BRISIGOTTI, M; MATIASGUIU, X; PRAT, J

    KERaTIN EXPRESSION IN NORMaL VULVa, NONNEOPLaSTIC EPITHELIaL DISORDERS, VULVaR INTRaEPITHELIaL NEOPLaSIa, aND INVaSIVE SQUaMOUS-CELL CaRCINOMa

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 10 341-355. .

    [doi:10.1097/00004347-199110000-00007]

  • ALEJO, M; MATIASGUIU, X; CABEZAS, R

    PaROTID LYMPHOEPITHELIaL BENIGN CYST IN a HIV PaTIENT

    REVISTA CLINICA ESPANOLA 189 195-196. .

  • ALEJO, M; MATIASGUIU, X; DURAN, PD

    INFaRCTION OF a PaPILLaRY THYROID-CaRCINOMa aFTER FINE NEEDLE aSPIRaTION

    ACTA CYTOL 35 478-479. .

  • PUJOL, RM; MATIASGUIU, X; GARCIAPATOS, V; DEMORAGAS, JM

    TUFTED-HaIR FOLLICULITIS

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 16 199-201. .

    [doi:10.1111/j.1365-2230.1991.tb00346.x]

  • MATIASGUIU, X; ESQUIUS, J

    LYMPHOEPITHELIaL LESION IN THE THYROID - a NONSPECIFIC HISTOLOGICaL FINDING

    PATHOL RES PRACT 187 296-300. .

  • MONES, J; WEBB, SM; BINIMELIS, J; MATIASGUIU, X; PEINADO, MA; FERRE, A

    CIRCULaTING HYPERSOMaTOSTaTINaEMIa IN MENETRIERS DISEaSE

    HORMON AND METABOLIC RESEARCH 23 146-147. .

    [doi:10.1055/s-2007-1003637]

  • ALEJO, M; PEIRO, G; OLIVA, E; MATIASGUIU, X

    LEU-M-1 IMMUNOREaCTIVITY IN PaPILLaRY CaRCINOMaS OF THE THYROID-GLaND - MICROCaRCINOMa, ENCaPSULaTED, CONVENTIONaL aND DIFFUSE SCLEROSING SUBTYPES

    Virchows Archiv A-Pathological Anatomy And Histopathology 419 447-447. .

    [doi:10.1007/BF01605080]

  • MATIASGUIU, X; ARANDA, I; PRAT, J

    IMMUNOHISTOCHEMICaL STUDY OF SaRCOMa-LIKE MURaL NODULES IN a MUCINOUS CYSTaDENOCaRCINOMa OF THE OVaRY

    Virchows Archiv A-Pathological Anatomy And Histopathology 419 89-92. .

    [doi:10.1007/BF01600221]

  • PUJOL, RM; MATIASGUIU, X; PLANAGUMA, M; DEMORAGAS, JM

    CHRONIC LYMPHOCYTIC-LEUKEMIa aND CUTaNEOUS GRaNULOMaS aT SITES OF HERPES-ZOSTER SCaRS

    International journal of dermatology 29 652-654. .

    [doi:10.1111/j.1365-4362.1990.tb02589.x]

  • MATIASGUIU, X; ALEJO, M; SOLE, T; FERRER, I; NOBOA, R; BARTUMEUS, F

    CaVERNOUS aNGIOMaS OF THE CRaNIaL NERVES - REPORT OF 2 CaSES

    Journal Of Neurosurgery 73 620-622. .

    [doi:10.3171/jns.1990.73.4.0620]

  • MATIASGUIU, X; PRAT, J

    OVaRIaN-TUMORS WITH FUNCTIONING STROMa - aN IMMUNOHISTOCHEMICaL STUDY OF 100 CaSES WITH HUMaN CHORIONIC-GONaDOTROPIN MONOCLONaL aND POLYCLONaL aNTIBODIES

    CANCER 65 2001-2005. .

    [doi:10.1002/1097-0142(19900501)65:9<2001::AID-CNCR2820650920>3.0.CO;2-7]

Projects

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU